vs
Side-by-side financial comparison of FEDERAL SIGNAL CORP (FSS) and Insulet Corporation (PODD). Click either name above to swap in a different company.
Insulet Corporation is the larger business by last-quarter revenue ($783.7M vs $597.1M, roughly 1.3× FEDERAL SIGNAL CORP). Insulet Corporation runs the higher net margin — 13.0% vs 10.2%, a 2.8% gap on every dollar of revenue. On growth, Insulet Corporation posted the faster year-over-year revenue change (31.2% vs 26.5%). FEDERAL SIGNAL CORP produced more free cash flow last quarter ($89.5M vs $48.2M). Over the past eight quarters, Insulet Corporation's revenue compounded faster (33.2% CAGR vs 18.5%).
The Federal Signal Company was an American manufacturer of railway signaling equipment in the early 20th century. It was located in Albany, New York.
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.
FSS vs PODD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $597.1M | $783.7M |
| Net Profit | $60.8M | $101.6M |
| Gross Margin | 28.4% | 72.6% |
| Operating Margin | 14.0% | 18.7% |
| Net Margin | 10.2% | 13.0% |
| Revenue YoY | 26.5% | 31.2% |
| Net Profit YoY | 21.6% | 0.9% |
| EPS (diluted) | $0.99 | $1.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $597.1M | $783.7M | ||
| Q3 25 | $555.0M | $706.3M | ||
| Q2 25 | $564.6M | $649.1M | ||
| Q1 25 | $463.8M | $569.0M | ||
| Q4 24 | $472.0M | $597.5M | ||
| Q3 24 | $474.2M | $543.9M | ||
| Q2 24 | $490.4M | $488.5M | ||
| Q1 24 | $424.9M | $441.7M |
| Q4 25 | $60.8M | $101.6M | ||
| Q3 25 | $68.1M | $87.6M | ||
| Q2 25 | $71.4M | $22.5M | ||
| Q1 25 | $46.3M | $35.4M | ||
| Q4 24 | $50.0M | $100.7M | ||
| Q3 24 | $53.9M | $77.5M | ||
| Q2 24 | $60.8M | $188.6M | ||
| Q1 24 | $51.6M | $51.5M |
| Q4 25 | 28.4% | 72.6% | ||
| Q3 25 | 29.1% | 72.2% | ||
| Q2 25 | 30.0% | 69.7% | ||
| Q1 25 | 28.2% | 71.9% | ||
| Q4 24 | 28.1% | 72.1% | ||
| Q3 24 | 29.6% | 69.3% | ||
| Q2 24 | 29.4% | 67.7% | ||
| Q1 24 | 27.3% | 69.5% |
| Q4 25 | 14.0% | 18.7% | ||
| Q3 25 | 16.9% | 16.7% | ||
| Q2 25 | 17.3% | 18.7% | ||
| Q1 25 | 14.2% | 15.6% | ||
| Q4 24 | 14.9% | 18.3% | ||
| Q3 24 | 16.0% | 16.2% | ||
| Q2 24 | 16.5% | 11.2% | ||
| Q1 24 | 12.8% | 12.9% |
| Q4 25 | 10.2% | 13.0% | ||
| Q3 25 | 12.3% | 12.4% | ||
| Q2 25 | 12.6% | 3.5% | ||
| Q1 25 | 10.0% | 6.2% | ||
| Q4 24 | 10.6% | 16.9% | ||
| Q3 24 | 11.4% | 14.2% | ||
| Q2 24 | 12.4% | 38.6% | ||
| Q1 24 | 12.1% | 11.7% |
| Q4 25 | $0.99 | $1.42 | ||
| Q3 25 | $1.11 | $1.24 | ||
| Q2 25 | $1.16 | $0.32 | ||
| Q1 25 | $0.75 | $0.50 | ||
| Q4 24 | $0.80 | $1.38 | ||
| Q3 24 | $0.87 | $1.08 | ||
| Q2 24 | $0.99 | $2.59 | ||
| Q1 24 | $0.84 | $0.73 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $63.7M | — |
| Total DebtLower is stronger | $564.6M | $930.8M |
| Stockholders' EquityBook value | $1.4B | $1.5B |
| Total Assets | $2.4B | $3.2B |
| Debt / EquityLower = less leverage | 0.41× | 0.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | — | ||
| Q3 25 | $54.4M | — | ||
| Q2 25 | $64.7M | — | ||
| Q1 25 | $57.5M | — | ||
| Q4 24 | $91.1M | — | ||
| Q3 24 | $73.7M | — | ||
| Q2 24 | $48.6M | — | ||
| Q1 24 | $48.9M | — |
| Q4 25 | $564.6M | $930.8M | ||
| Q3 25 | $201.2M | $934.9M | ||
| Q2 25 | $258.3M | $939.0M | ||
| Q1 25 | $266.9M | $1.6B | ||
| Q4 24 | $204.4M | $1.3B | ||
| Q3 24 | $223.3M | $1.4B | ||
| Q2 24 | $248.8M | $1.4B | ||
| Q1 24 | $266.8M | $1.4B |
| Q4 25 | $1.4B | $1.5B | ||
| Q3 25 | $1.3B | $1.4B | ||
| Q2 25 | $1.3B | $1.5B | ||
| Q1 25 | $1.2B | $1.3B | ||
| Q4 24 | $1.2B | $1.2B | ||
| Q3 24 | $1.1B | $1.1B | ||
| Q2 24 | $1.1B | $998.4M | ||
| Q1 24 | $1.0B | $790.7M |
| Q4 25 | $2.4B | $3.2B | ||
| Q3 25 | $1.9B | $3.0B | ||
| Q2 25 | $1.9B | $3.5B | ||
| Q1 25 | $1.9B | $3.5B | ||
| Q4 24 | $1.8B | $3.1B | ||
| Q3 24 | $1.7B | $3.0B | ||
| Q2 24 | $1.7B | $2.9B | ||
| Q1 24 | $1.7B | $2.6B |
| Q4 25 | 0.41× | 0.61× | ||
| Q3 25 | 0.15× | 0.68× | ||
| Q2 25 | 0.20× | 0.64× | ||
| Q1 25 | 0.22× | 1.21× | ||
| Q4 24 | 0.17× | 1.07× | ||
| Q3 24 | 0.19× | 1.21× | ||
| Q2 24 | 0.23× | 1.36× | ||
| Q1 24 | 0.26× | 1.72× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $97.2M | $183.3M |
| Free Cash FlowOCF − Capex | $89.5M | $48.2M |
| FCF MarginFCF / Revenue | 15.0% | 6.2% |
| Capex IntensityCapex / Revenue | 1.3% | 17.2% |
| Cash ConversionOCF / Net Profit | 1.60× | 1.80× |
| TTM Free Cash FlowTrailing 4 quarters | $227.1M | $377.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $97.2M | $183.3M | ||
| Q3 25 | $61.1M | $125.7M | ||
| Q2 25 | $59.7M | $196.5M | ||
| Q1 25 | $36.7M | $63.8M | ||
| Q4 24 | $90.6M | $147.7M | ||
| Q3 24 | $68.8M | $98.5M | ||
| Q2 24 | $40.6M | $96.5M | ||
| Q1 24 | $31.3M | $87.6M |
| Q4 25 | $89.5M | $48.2M | ||
| Q3 25 | $54.1M | $100.1M | ||
| Q2 25 | $52.4M | $177.9M | ||
| Q1 25 | $31.1M | $51.5M | ||
| Q4 24 | $82.1M | $94.1M | ||
| Q3 24 | $60.9M | $71.8M | ||
| Q2 24 | $24.8M | $74.0M | ||
| Q1 24 | $22.9M | $65.5M |
| Q4 25 | 15.0% | 6.2% | ||
| Q3 25 | 9.7% | 14.2% | ||
| Q2 25 | 9.3% | 27.4% | ||
| Q1 25 | 6.7% | 9.1% | ||
| Q4 24 | 17.4% | 15.7% | ||
| Q3 24 | 12.8% | 13.2% | ||
| Q2 24 | 5.1% | 15.1% | ||
| Q1 24 | 5.4% | 14.8% |
| Q4 25 | 1.3% | 17.2% | ||
| Q3 25 | 1.3% | 3.6% | ||
| Q2 25 | 1.3% | 2.9% | ||
| Q1 25 | 1.2% | 2.2% | ||
| Q4 24 | 1.8% | 9.0% | ||
| Q3 24 | 1.7% | 4.9% | ||
| Q2 24 | 3.2% | 4.6% | ||
| Q1 24 | 2.0% | 5.0% |
| Q4 25 | 1.60× | 1.80× | ||
| Q3 25 | 0.90× | 1.43× | ||
| Q2 25 | 0.84× | 8.73× | ||
| Q1 25 | 0.79× | 1.80× | ||
| Q4 24 | 1.81× | 1.47× | ||
| Q3 24 | 1.28× | 1.27× | ||
| Q2 24 | 0.67× | 0.51× | ||
| Q1 24 | 0.61× | 1.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FSS
| Vehiclesandequipment | $403.4M | 68% |
| Parts | $66.8M | 11% |
| Publicsafetyandsecurityequipment | $62.2M | 10% |
| Rentalincome | $19.0M | 3% |
| Industrialsignalingequipment | $18.2M | 3% |
| Other | $14.9M | 2% |
| Warningsystems | $12.6M | 2% |
PODD
| U.S.Omnipod | $567.8M | 72% |
| International Omnipod | $214.0M | 27% |
| Drug Delivery | $1.9M | 0% |
